PACIO Transitions of Care Implementation Guide
1.0.0 - STU 1 US

This page is part of the PACIO Transitions of Care Implementation Guide (v1.0.0: STU 1) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions

Example AllergyIntolerance: Example: Allergy List

Page standards status: Informative

Profile: US Core AllergyIntolerance Profile version: 8.0.1

clinicalStatus: Active

verificationStatus: Confirmed

category: Medication

criticality: High Risk

code: Substance with angiotensin-converting enzyme inhibitor mechanism of action (substance)

patient: Smith-Johnson, Betsy Female, DoB: 1958-11-01 ( http://hl7.org/fhir/sid/us-medicare#United States Medicare Number#1AA3D58WH16)

asserter: Smith-Johnson, Betsy Female, DoB: 1958-11-01 ( http://hl7.org/fhir/sid/us-medicare#United States Medicare Number#1AA3D58WH16)

lastOccurrence: 2011-10

Reactions

-SubstanceManifestation
*captopril 12.5 MG Oral TabletHyperkalemia caused by angiotensin-converting enzyme inhibitor (disorder)